318 related articles for article (PubMed ID: 25188375)
41. Classification of Postprandial Glycemic Status with Application to Insulin Dosing in Type 1 Diabetes-An In Silico Proof-of-Concept.
Cappon G; Facchinetti A; Sparacino G; Georgiou P; Herrero P
Sensors (Basel); 2019 Jul; 19(14):. PubMed ID: 31323886
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the post-meal glucose response to different insulin bolus waveforms in insulin pump- and pre-meal pramlintide-treated type 1 diabetes patients.
King AB
Diabetes Technol Ther; 2010 Feb; 12(2):105-8. PubMed ID: 20105039
[TBL] [Abstract][Full Text] [Related]
43. Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion.
Zisser H; Dassau E; Lee JJ; Harvey RA; Bevier W; Doyle FJ
J Diabetes Sci Technol; 2015 May; 9(3):564-72. PubMed ID: 25901023
[TBL] [Abstract][Full Text] [Related]
44. Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals.
Cameron F; Niemeyer G; Wilson DM; Bequette BW; Benassi KS; Clinton P; Buckingham BA
Diabetes Technol Ther; 2014 Nov; 16(11):728-34. PubMed ID: 25259939
[TBL] [Abstract][Full Text] [Related]
45. Postprandial hyperglycaemia following insulin suspensions by the artificial pancreas: Implications for bolus calculators.
Major S; El Fathi A; Palisaitis E; Kearney R; Von Oettingen JE; Krishnamoorthy P; Legault L; Haidar A
Diabetes Obes Metab; 2020 Aug; 22(8):1474-1477. PubMed ID: 32533655
[TBL] [Abstract][Full Text] [Related]
46. Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting.
Smart CE; Ross K; Edge JA; Collins CE; Colyvas K; King BR
Diabet Med; 2009 Mar; 26(3):279-85. PubMed ID: 19317823
[TBL] [Abstract][Full Text] [Related]
47. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
Shashaj B; Busetto E; Sulli N
Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
[TBL] [Abstract][Full Text] [Related]
48. Does the fat-protein meal increase postprandial glucose level in type 1 diabetes patients on insulin pump: the conclusion of a randomized study.
Pańkowska E; Błazik M; Groele L
Diabetes Technol Ther; 2012 Jan; 14(1):16-22. PubMed ID: 22013887
[TBL] [Abstract][Full Text] [Related]
49. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
[TBL] [Abstract][Full Text] [Related]
50. Use of Sitagliptin With Closed-Loop Technology to Decrease Postprandial Blood Glucose in Type 1 Diabetes.
Underland LJ; Ilkowitz JT; Katikaneni R; Dowd A; Heptulla RA
J Diabetes Sci Technol; 2017 May; 11(3):602-610. PubMed ID: 28349708
[TBL] [Abstract][Full Text] [Related]
51. Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes.
Kanderian SS; Weinzimer S; Voskanyan G; Steil GM
J Diabetes Sci Technol; 2009 Sep; 3(5):1047-57. PubMed ID: 20144418
[TBL] [Abstract][Full Text] [Related]
52. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
[TBL] [Abstract][Full Text] [Related]
53. Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial.
Gingras V; Smaoui MR; Cameli C; Messier V; Ladouceur M; Legault L; Rabasa-Lhoret R
Sci Rep; 2018 Feb; 8(1):2621. PubMed ID: 29422651
[TBL] [Abstract][Full Text] [Related]
54. Advanced hybrid artificial pancreas system improves on unannounced meal response - In silico comparison to currently available system.
Garcia-Tirado J; Lv D; Corbett JP; Colmegna P; Breton MD
Comput Methods Programs Biomed; 2021 Nov; 211():106401. PubMed ID: 34560603
[TBL] [Abstract][Full Text] [Related]
55. A Comparison of Postprandial Glucose Control in the Medtronic Advanced Hybrid Closed-Loop System Versus 670G.
Weinzimer SA; Bailey RJ; Bergenstal RM; Nimri R; Beck RW; Schatz D; Ambler-Osborn L; Schweiger DS; von dem Berge T; Sibayan J; Johnson ML; Calhoun P; Phillip M;
Diabetes Technol Ther; 2022 Aug; 24(8):573-582. PubMed ID: 35363054
[No Abstract] [Full Text] [Related]
56. Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era.
Bell KJ; Smart CE; Steil GM; Brand-Miller JC; King B; Wolpert HA
Diabetes Care; 2015 Jun; 38(6):1008-15. PubMed ID: 25998293
[TBL] [Abstract][Full Text] [Related]
57. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
58. Combining basal-bolus insulin infusion for tight postprandial glucose control: an in silico evaluation in adults, children, and adolescents.
Revert A; Rossetti P; Calm R; Vehí J; Bondia J
J Diabetes Sci Technol; 2010 Nov; 4(6):1424-37. PubMed ID: 21129338
[TBL] [Abstract][Full Text] [Related]
59. Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.
Grosman B; Dassau E; Zisser HC; Jovanovic L; Doyle FJ
J Diabetes Sci Technol; 2010 Jul; 4(4):961-75. PubMed ID: 20663463
[TBL] [Abstract][Full Text] [Related]
60. Artificial pancreas using a personalized rule-based controller achieves overnight normoglycemia in patients with type 1 diabetes.
Capel I; Rigla M; García-Sáez G; Rodríguez-Herrero A; Pons B; Subías D; García-García F; Gallach M; Aguilar M; Pérez-Gandía C; Gómez EJ; Caixàs A; Hernando ME
Diabetes Technol Ther; 2014 Mar; 16(3):172-9. PubMed ID: 24152323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
